MedPath

Microneedling with 70% gylcolic acid peel for treatment of atrophic acne scars

Not Applicable
Completed
Registration Number
CTRI/2014/12/005292
Lead Sponsor
ady hardinge medical college
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1)all patients of acne scars, with minimun scoring of 15(according to ECCA grading scale)

2)those who give written consent for the study

3) patients older than 18 years

Exclusion Criteria

1)Patient who has taken systemic retinoids or immunosuppressive drug in last 6 month

2)Pt. With coagulation defect or bleeding disorder

3)Pt. With history or evidence of keloid scars

4)Pregnancy or lactation

5)Pt with active acne lesion

6)Unrealistic expectation

7) patient on anti deprassant

8) sensitive to test peel

9) patient with active or recurrent herpes

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
reduction in ECCA score at 22 week, after completing full course of treatmentTimepoint: 22 weeks
Secondary Outcome Measures
NameTimeMethod
1)Overall improvement in skin texture according to visual analoge scoring <br/ ><br>2)Reduction in downtime between two groups. <br/ ><br>Timepoint: 22 weeks
© Copyright 2025. All Rights Reserved by MedPath